News

July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two investigational device exemptions (IDEs) to study the use of the ThermoSuit system in...

therapeutic hypothermia, Philips InnerCool

Use of therapeutic hypothermia is used to prevent neurological damage in patients who suffer sudden cardiac arrest (SCA), and there are many advocates suggesting a similar approach can...

rhinochill, RhinoChill, benechill, BeneChill

With the benefits of conventional strategies for therapeutic hypothermia following cardiac arrest being called in to question following the publication of two new studies, brain...

therapeutic hypothermia temperature management cath lab clinical trial study

clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

Royal has completed patient enrollment in the CHILL-MI clinical study designed to further evaluate the safety and effectiveness of the company’s InnerCool RTx endovascular cooling system in...

February 16, 2012 — Velomedix Inc., a clinical stage medical device company, announced it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (...

January 26, 2012 — The RhinoChill IntraNasal cooling system has been nominated for one of the European medical device industry’s most prestigious awards.

January 16, 2012 — Philips Healthcare announced the enrollment of the first patients in its CHILL-MI clinical study. The RAPID MI-ICE trial showed a 38 percent reduction in infarct size in STEMI...

September 12, 2011 — Life Recovery Systems (LRS) announced it has been awarded a new three-year agreement by Premier Purchasing Partners LP (PPP), the group purchasing unit of the Premier...

August 23, 2011 — Cardium Therapeutics received the final $1.1 million payment from Royal Philips Electronics in connection with Philips' acquisition of Innercool Therapies from Cardium. The...

February 9, 2011 – A partnership has been formed to launch a portable therapeutic cooling system in Europe. Physio-Control and BeneChill will work together to launch the RhinoChill IntraNasal...

November 1, 2010 - After a heart attack victim stops breathing, a process of irreversible brain damage starts to occur within three to four minutes. But a new technique may significantly delay...

October 20, 2010 - The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched the first large-scale, multicenter study to investigate the...

September 15, 2010 – The U.S. Food and Drug Administration (FDA) granted 510(k) market approval for the Medivance noninvasive Arctic Sun 5000 therapeutic temperature management device. The new...

August 18, 2010 - A new portable system which cools the brain via the nasal cavity may improve survival following cardiac arrest compared with standard care procedures, particularly when...

August 9, 2010 - Health care professionals will attend a conference devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other...

August 3, 2010 — St. Joseph’s Regional Medical Center (SJRMC) in Paterson, N.J., received the Chain of Survival Award from the Sudden Cardiac Arrest Association and accolades from New Jersey Gov....

June 16, 2010 – A new therapeutic hypothermia system promises faster cooling and warming rates as well as precise temperature control. Royal Philips Electronics recently announced the launch of...

June 10, 2010 – There is currently no proven therapy to reduce infarct volume, but a pilot study demonstrated use of mild hypothermia (below 35 C) in ST-elevated myocardial infarction (STEMI)...